BrightSpring Health Services, Inc. (NASDAQ:BTSG) Shares Purchased by Legato Capital Management LLC

Legato Capital Management LLC boosted its position in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 40.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 66,910 shares of the company’s stock after buying an additional 19,120 shares during the period. Legato Capital Management LLC’s holdings in BrightSpring Health Services were worth $1,139,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently bought and sold shares of BTSG. R Squared Ltd purchased a new stake in shares of BrightSpring Health Services in the 4th quarter valued at $74,000. Intech Investment Management LLC acquired a new position in BrightSpring Health Services during the third quarter valued at $159,000. nVerses Capital LLC boosted its holdings in BrightSpring Health Services by 195.8% in the third quarter. nVerses Capital LLC now owns 14,200 shares of the company’s stock valued at $208,000 after purchasing an additional 9,400 shares during the last quarter. BNP Paribas Financial Markets grew its position in BrightSpring Health Services by 5.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 21,329 shares of the company’s stock worth $313,000 after purchasing an additional 1,011 shares during the period. Finally, SG Americas Securities LLC purchased a new position in shares of BrightSpring Health Services during the 3rd quarter valued at about $360,000.

BrightSpring Health Services Trading Down 1.4 %

BTSG stock opened at $21.67 on Thursday. BrightSpring Health Services, Inc. has a 12-month low of $7.85 and a 12-month high of $24.82. The business’s 50-day moving average is $19.40 and its 200 day moving average is $16.58. The company has a current ratio of 1.35, a quick ratio of 0.97 and a debt-to-equity ratio of 1.63. The stock has a market cap of $3.77 billion and a price-to-earnings ratio of -83.35.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Bank of America upped their target price on BrightSpring Health Services from $19.00 to $21.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Wells Fargo & Company upped their price objective on BrightSpring Health Services from $17.00 to $21.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 27th. UBS Group lifted their target price on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. CJS Securities assumed coverage on shares of BrightSpring Health Services in a report on Thursday, December 12th. They set an “outperform” rating and a $27.00 price target on the stock. Finally, Morgan Stanley raised their price target on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the company an “overweight” rating in a research report on Tuesday, December 17th. One equities research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $19.42.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.